Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

India is facing a major health crisis, with rising obesity rates across all age groups, leading to increased early mortality ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to ...

Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.

Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.

In dogs with pancreatitis, the digestive enzymes don’t flow to the intestines to digest food as they should but instead start ...

Glucagon-like peptide 1 ... reports of some patients experiencing nasty side effects, such as persistent vomiting and stomach paralysis. Additionally, a large study published in 2025 revealed ...

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Linda Gigliotti, MS, RDN, CDCES, FAND, about combining the use of GLP-1 ...

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...